INFLAMMATORY + ATOPIC CONDITIONS CARE VALUE Trademark

Trademark Overview


On Thursday, February 17, 2022, a trademark application was filed for INFLAMMATORY + ATOPIC CONDITIONS CARE VALUE with the United States Patent and Trademark Office. The USPTO has given the INFLAMMATORY + ATOPIC CONDITIONS CARE VALUE trademark a serial number of 97271623. The federal status of this trademark filing is REGISTERED as of Tuesday, January 16, 2024. This trademark is owned by Express Scripts Strategic Development, Inc.. The INFLAMMATORY + ATOPIC CONDITIONS CARE VALUE trademark is filed in the Advertising, Business and Retail Services and Insurance & Financial Services categories with the following description:

Pharmacy benefit management consulting services; Insurance administration of pharmacy benefit plans

Cost management for the health and prescription drug plans of others in the field of pharmaceuticals, clinical care and health care treatment; business services, namely, prescription drug formulary cost management services; consulting services regarding healthcare costs and retail pharmacy services
inflammatory + atopic conditions care value

General Information


Serial Number97271623
Word MarkINFLAMMATORY + ATOPIC CONDITIONS CARE VALUE
Filing DateThursday, February 17, 2022
Status700 - REGISTERED
Status DateTuesday, January 16, 2024
Registration Number7281302
Registration DateTuesday, January 16, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Pseudo MarkINFLAMMATORY PLUS ATOPIC CONDITIONS CARE VALUE
Goods and ServicesPharmacy benefit management consulting services; Insurance administration of pharmacy benefit plans
Goods and ServicesCost management for the health and prescription drug plans of others in the field of pharmaceuticals, clinical care and health care treatment; business services, namely, prescription drug formulary cost management services; consulting services regarding healthcare costs and retail pharmacy services
Disclaimer with Predetermined Text"INFLAMMATORY AND ATOPIC CONDITIONS"

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, February 23, 2022
Primary Code035
First Use Anywhere DateMonday, February 28, 2022
First Use In Commerce DateMonday, February 28, 2022

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateWednesday, February 23, 2022
Primary Code036
First Use Anywhere DateMonday, February 28, 2022
First Use In Commerce DateMonday, February 28, 2022

Trademark Owner History


Party NameExpress Scripts Strategic Development, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSt. Louis, MO 63121

Party NameExpress Scripts Strategic Development, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSt. Louis, MO 63121

Trademark Events


Event DateEvent Description
Tuesday, January 16, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 16, 2024REGISTERED-SUPPLEMENTAL REGISTER
Monday, September 18, 2023EXPARTE APPEAL TERMINATED
Friday, August 11, 2023NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Thursday, August 10, 2023APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Thursday, August 10, 2023USE AMENDMENT ACCEPTED
Thursday, July 6, 2023EX PARTE APPEAL-INSTITUTED
Thursday, July 6, 2023JURISDICTION RESTORED TO EXAMINING ATTORNEY
Thursday, July 6, 2023EXPARTE APPEAL RECEIVED AT TTAB
Wednesday, May 17, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, May 16, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, May 16, 2023TEAS REQUEST FOR RECONSIDERATION RECEIVED
Wednesday, May 17, 2023AMENDMENT TO USE PROCESSING COMPLETE
Wednesday, May 17, 2023USE AMENDMENT FILED
Tuesday, May 16, 2023TEAS AMENDMENT OF USE RECEIVED
Thursday, April 6, 2023NOTIFICATION OF FINAL REFUSAL EMAILED
Thursday, April 6, 2023FINAL REFUSAL E-MAILED
Thursday, April 6, 2023FINAL REFUSAL WRITTEN
Tuesday, February 28, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 27, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 27, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Saturday, August 27, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Saturday, August 27, 2022NON-FINAL ACTION E-MAILED
Saturday, August 27, 2022NON-FINAL ACTION WRITTEN
Friday, August 19, 2022ASSIGNED TO EXAMINER
Wednesday, February 23, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, February 21, 2022NEW APPLICATION ENTERED